Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR , underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls ( P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells ( P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, patients with IPF who have mutant telomerase genes are at an increased risk of developing bone marrow failure and liver disease54,71.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, telomere dysfunction in epithelial cells, or perhaps another cell type, might cause parenchymal organ remodelling, which manifests as fibrosis and/or emphysema46,54,99.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, circulating leukocytes and alveolar epithelial cells show shorter telomeres than age-matched individuals53.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
From The telomere syndromes (2012) · cites this paper as [54]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lead SNPs at two loci (TERC and TERT) associate with several cancers and other diseases, including idiopathic pulmonary fibrosis.”
From Identification of seven loci affecting mean telomere length and their association with disease (2013) · cites this paper as [26]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 6×
“In IPF families with telomerase mutations, cases of aplastic anemia can be hidden and are uncovered after a thorough family history, suggesting that mutations in telomerase have heterogeneous manifestations in an individual patient and within families, and that a subset of families with IPF falls on the same spectrum…”
BackgroundInfluentialSelf-citationEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Cited by
Items 701–800 of 802
High CXCL6 drives matrix expression and correlate with markers of poor outcome in IPFPreprint
Bahudhanapati, H., Tan, J., Apel, R. M., Seeliger, B., Li, X., Chen, T., Sullivan, D. I., Sembrat, J., Rojas, M. M., Tabib, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.22.449424 · Cited by 1
“Baseline DLCO%, median (IQR) 52 (39-62) 54 (41-70)”
BackgroundSelf-citationCottin, V., & Kolb, M. R. J. (2023) · European Respiratory Journal · doi:10.1183/13993003.01852-2023 · Cited by 1
Pulmonary Disorders: Hereditary
Marciniak, S. J., & Lomas, D. A. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0005517.pub2
COPD as a Disease of Premature Aging
Boyer, L., Boczkowski, J., & Adnot, S. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch13
Calado, R. T. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch4
Telomere Dysfunction in Human Genetic Disease
Morgan, G., & Ly, H. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0023585
The Genetics of Pulmonary Fibrosis
Danoff, S. K., & Johnson, C. R. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_9
Self-citationRivera, J. Á. P. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.124198
Interstitial Lung Disease in Older Patients
Antin-Ozerkis, D. E. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-727-3_11
Bone Marrow Failure Syndromes and Refractory Cytopenia of Childhood
Aalbers, A. M. (2014) · EUR Research Repository (Erasmus University Rotterdam)
Familial Idiopathic Pulmonary Fibrosis: A Case Series and Review of the Literature
Izett, M., Leahy, A., & Jarad, N. A. (2011) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e31822c969b
“Telomere shortening alone has been found to be a risk factor for developing IPF, irrespective of telomerase mutations or family history.(29) Surfactant protein C mutations are also thought to play a role in FIPF.”
Background3. Clinical Practice of Interstitial Lung Disease
Nukiwa, T. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.2112
Byrne, R. (2015) · Memorial University Research Repository (Memorial University)
Structure and Functions of Telomeres in Organismal Homeostasis and Disease
Kroustallaki, P., & Gagos, S. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3070-8_10
Regenerative Cells in the Ageing Lung
Hoffman, A. M. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-21082-7_8
Genomics of Lung Aging and Idiopathic Pulmonary Fibrosis
Juan-Guardela, B. M., & Kaminski, N. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814635011_0015
da Silva, V. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-14122015-145516
The Cellular Senescence Program
Shivshankar, P., & Saux, C. J. L. (2014) · Wiley eBooks · doi:10.1002/9781118396292.ch5
Telomeres in Liver Transplantation Allografts
Tsuruyama, T., & Aini, W. (2016) · InTech eBooks · doi:10.5772/62196
“Short telomeres are a risk factor for the develop‐ ment of idiopathic pulmonary fibrosis [49].”
Lung transplantation in idiopathic pulmonary fibrosis: old & new concepts
ten Klooster, L. (2016) · Utrecht University Repository (Utrecht University)
INVITED REVIEW SERIES: PULMONARY FIBROSIS
Kolb, M. R. J., Cox, G., & Behr, J. (2009)
Human Lung Progenitor Populations in End-stage Lung Disease and Transplantation.
Gilpin, S. E. (2012) · TSpace (University of Toronto)
Genetic susceptibility to familial interstitial pneumonia and idiopathic pulmonary fibrosis
Mihalek, A. D., Hunninghake, G. M., & Rosas, I. O. (2015) · doi:10.2217/fmeb2013.14.97
Suda, T. (2018) · Respiratory disease series · doi:10.1007/978-981-10-8144-6_7
Genetics of Pulmonary Fibrosis
Keith, R. C., Brown, K. K., & Fingerlin, T. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54431-3.00004-4
Imaging of Idiopathic Pulmonary Fibrosis
Richards, J. C., & Koelsch, T. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54431-3.00005-6
Aspectos clínicos e genéticos de pacientes brasileiros com Pneumonia Intersticial Familiar
Hortense, A. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-13092018-084314
Interstitial Lung Disease Registry Report
Ansarie, M. (2019) · INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) · doi:10.29052/ijehsr.v7.i1.2019.61-100
Telomere-Related Gene Mutations and Lung Diseases: Pulmonary Fibrosis, Emphysema and Lung Cancer
Sastre, L., Molina‐Molina, M., & Perona, R. (2019) · Barcelona Respiratory Network · doi:10.23866/brnrev:2018-0010 · Cited by 2
Genetic Pediatric Pulmonary Disease
Hawley, M. H., Moschovis, P. P., Kinane, T. B., & Yonker, L. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-23979-4_9
Fontenot, A. P., & Simonian, P. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00085-4
Morphological and functional studies in a sheep model of pulmonary fibrosis
Dewage, V., & Nimanthi, S. (2020) · Minerva Access (University of Melbourne)
Is Immune Response Relevant in Interstitial Lung Disease?
Khan, M. M. (2020) · Current Immunology Reviews · doi:10.2174/1573395516999200914143054
A Comprehensive Guide to Lung Transplantation for the Recipient With Pulmonary Fibrosis
Kolaitis, N. A., & Shah, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00080-9
Senotherapeutics: Experimental therapy of cellular senescence
Justice, J. N., Niedernhofer, L. J., & Orr, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00012-3
Idelevich, P., & Reed, K. M. (2021) · Research Square · doi:10.21203/rs.3.rs-203231/v1
“Alder et al. (2008) Cronkhite et al. (2008) Interestingly, nearly all patients with IPF have short telomeres even in the absence of TERT or TERC mutations. Armanios (2012) MUC5B promoter region rs35705950, a common gain-of-function variant with low penetrance, has been con rmed as the risk factor for development of bo…”
BackgroundInfluentialMarkart, P., Drakopanagiotakis, F., & Wygrecka, M. (2021) · Der Pneumologe · doi:10.1007/s10405-021-00383-4
“TERTund TERC-Mutationen mit abnorm verkürzten Telomeren finden sich bei 8–15% der Patienten mit familiärer pulmonaler Fibrose und bei bis zu 3% der sporadischen Fälle einer IPF [1, 5, 32].”
BackgroundCellular Mechanisms in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Rojas, M. M., Albacar, N., & Cuerpo, S. (2026) · Barcelona Respiratory Network · doi:10.23866/brnrev:2020-0010
Nogueiras‐Álvarez, R., Cuesta, V. M. M., Martínez, J. M. C., de Cos, M. A., & Sáiz, M. G. (2021) · Transplantology · doi:10.3390/transplantology2040045
Shared inter-generational collaborative problem solving play spaces
Siyahhan, S., Barab, S. A., & Downton, M. (2008) · International Conference of Learning Sciences
Review of the British Thoracic Society Winter Meeting 2017, 6–8 December 2017, London, UK
Singanayagam, A., Woodcock, H. V., Molyneaux, P. L., & Jenkins, G. R. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-212012
(2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283328098
Interaction Between Epithelial and Mesenchymal Cells in Interstitial Lung Disease
Cohen, M., & Wolters, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11657-5
Respiratory Homeostatic Dysfunction, Lower Respiratory Tract Dysfunction
(2014) · CRC Press eBooks · doi:10.1201/b17276-4
Sandbo, N. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_7
Telomere maintenance and genome stability
Huang, W., Hernandez-Sanchez, W. M., Xu, M., & Taylor, D. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00021-0
Markart, P., Drakopanagiotakis, F., & Wygrecka, M. (2022) · Wiener klinisches Magazin · doi:10.1007/s00740-022-00438-z
“TERTund TERC-Mutationen mit abnorm verkürzten Telomeren finden sich bei 8–15% der Patienten mit familiärer pulmonaler Fibrose und bei bis zu 3% der sporadischen Fälle einer IPF [1, 5, 32].”
BackgroundGarcia, C. K., Xing, C., Rosenblatt, R. L., Cronkhite, J. T., & Raghu, G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.179.9.852a
A clinical short‐cut to identifying short telomeres in idiopathic pulmonary fibrosis?
Maher, T. M. (2022) · Respirology · doi:10.1111/resp.14355
Zeybel, M., & Mann, D. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00262-5
Research Progress of Prognostic Biomarkers in Idiopathic Pulmonary Fibrosis
任, 静. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12101384
Rare Diffuse Lung Diseases of Genetic Origin
Spagnolo, P., & Bernardinello, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_28
Zhan, Y., Gu, Y., Yang, R., Deng, Z., Chen, S., Huang, Q., Wu, J., Chen, J., & Xie, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3304066/v1
Self-citationOwuor, J. O., & Soubani, A. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00020-7
The Correlation Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Liu, Y. (2024) · Transactions on Materials Biotechnology and Life Sciences · doi:10.62051/ybhfac94
“Their modification was also proved common in patients of IPF with no family history [5].”
BackgroundKannengiesser, C., & Revy, P. (2024) · Wiley eBooks · doi:10.1002/9781394300808.ch12
Idelevich, P., & Reed, K. L. (2024) · Research Square · doi:10.21203/rs.3.rs-4777803/v1
Su, B., Cui, F., Wu, Y., Chen, C., Xie, J., Wang, Y., Zhong, P., Tian, Y., Zheng, X., & Chen, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5002820
Closing the Loop on Diagnostic Testing in Interstitial Lung Disease
Chambers, D. C., & Mackintosh, J. A. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.08.001
Chen, J. J., Liu, H., Pang, Y., Wang, Y., Ren, Z., Liu, J., Yang, N., & Liu, D. (2024) · Biological Research For Nursing · doi:10.1177/10998004241303536
“Short telomeres are associated with adverse health outcomes, such as a higher risk of ischemic heart disease and idiopathic pulmonary fi brosis, and worse outcomes in coronavirus disease-19 patients (Alder et al., 2008; Scheller Madrid et al., 2016; Wang et al., 2021).”
Self-citationAnimal and Translational Models for Precision Medicine in ILD
Katzen, J. B., & Knipe, R. S. (2025) · Respiratory medicine · doi:10.1007/978-3-031-87183-2_9
Genetic Biomarkers for Interstitial Lung Disease
Zhang, D., & Newton, C. A. (2025) · Respiratory medicine · doi:10.1007/978-3-031-87183-2_3
Mahieu, M., Defour, J., Mathieu, B., Richiardone, E., Heremans, I. P., Fabiole, E., Levy, G., Berre, G. L., Scheers, I., Brichard, B., et al. (2025) · eLife · doi:10.1101/2025.06.27.661964
Calvi, C. L., Winters, N. I., McCall, A. S., Fernandez, R. J., Gninzeko, F. J. K., Ding, H., Nichols, D. S., Polosukhin, V. V., Sucre, J. M. S., Gokey, J. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.04.674361
“Recognizing that fibroblast senescence (55) and short telomeres in circulating immune cells (16) have also been linked to PF, we also considered the possibility that other cell types (such as myeloid cells or fibroblasts) might mediate the effects on Rtel1 on fibrogenesis.”
Tomos, I., Dimakopoulou, K., Manali, E. D., Papiris, S. A., & Karakatsani, A. (2021) · Figshare · doi:10.6084/m9.figshare.16544305
Koteci, A., Morgan, A. D., Portas, L., Whittaker, H., Kallis, C., George, P., & Quint, J. K. (2022) · Figshare · doi:10.6084/m9.figshare.19759517
Usategui, A., Municio, C., Arias‐Salgado, E. G., Martín, M., Fernández-Varas, B., Rey, M. J. D., Carreira, P., Gonzalez, A., Criado, G., Perona, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19084074
Usategui, A., Municio, C., Arias‐Salgado, E. G., Martín, M., Fernández-Varas, B., Rey, M. J. D., Carreira, P., Gonzalez, A., Criado, G., Perona, R., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19084077
Kawasaki, A., Namba, N., Sada, K., Hirano, F., Kobayashi, S., Nagasaka, K., Sugihara, T., Ono, N., Fujimoto, T., Kusaoi, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13115195
Liang, L., Cai, Y. S., Lyu, B., Zhang, D., Chu, S., Jing, H., Rahimi, K., & Tong, Z. (2022) · Figshare · doi:10.6084/m9.figshare.19522583
Short Telomere Syndrome and Interstitial Lung Diseases: An Updated Clinical Review (2025)
Ahmed, S. (2025) · PULMON · doi:10.4103/pulmon.pulmon_26_25 · Cited by 1
Read, J. M., Reid, A. T., Thomson, C., Plit, M., La, Q. T., Mejia, R., Saxena, P., Knight, D. A., Lizé, M., Prêle, C. M., et al. (2026) · ERJ Open Research · doi:10.1183/23120541.01212-2025
“Evidence for a causative role of senescence in IPF includes the linkage of mutations in telomere-related genes (TRGs) that accelerate telomere attrition [13].”
Nintedanib and Pirfenidone Affect Growth and Differentiation of Human Alveolar Type 2 CellsPreprint
Bazarov, A. V., Serra-Marques, A., Protti, G., Yang, M. M., Naikawadi, R. P., Green, G. A., Lee, S., Kukreja, J., Matthay, M. A., Wax, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.02.708135
The interplay of airway epithelium and biomechanical stress in pulmonary fibrosis
Lin, L., Khoury, J., Zhang, G., Szafron, J. M., Manning, E. P., & Ahangari, F. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag066
Rôle de la voie hedgehog dans la fibrose pulmonaire idiopathique
Moshai, E. F. (2013) · theses.fr (ABES) · doi:10.70675/b550340ez33a1z43b7zb4eez8c2cfde874df
Ngangue, E. C.-N. (2012) · theses.fr (ABES) · doi:10.70675/b9e28642z5037z4fceza4d6za62be310d18d · Cited by 1
Implication de FGF9 et de FGF19 dans la fibrose pulmonaire idiopathique
Justet, A. (2020) · theses.fr (ABES) · doi:10.70675/6e72f095z0cb6z4dd3zb204z88d1b08b9910
Rôle des plaquettes dans la fibrose pulmonaire et l'anévrisme intracrânien
Martos, R. (2022) · theses.fr (ABES) · doi:10.70675/75ba5efez9d6ez41c2zbeddz24cc271f253e
Zhao, X., Ding, W., Zhang, L., Cai, Q., Lu, Z., Huang, W., Xie, W., & Kong, H. (2026) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073468105260421052108
Hirsch, T. I., Miller, W. P., Tsikis, S. T., Arévalo-Alquichire, S., Kaplan, B. A., Barake, K. W., Gunawan, A. L., Vanderleest, T. E., Vijikumar, A., Sanchez-Suarez, J., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-55553-2
“During disease progression, dysfunctional alveolar epithelial cells fail to proliferate and instead release profibrotic mediators that facilitate differentiation of lung tissue and ECM accumulation 15,16 .”
Interstitial Lung Disease in Rheumatic Diseases
Forte, G., Ciancio, A., & Liakouli, V. (2026) · Contemporary rheumatology · doi:10.1007/978-3-032-22966-3_9
Zhan, H., Zheng, R., Li, Y., Liu, X. W., Shi, Y., Chen, R., Hou, Q., Huang, H. F., & Lin, M. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.034
“This supports the idea that the short telomere in IPF is systemic 15,50,53 .”
InfluentialShort for their age: interpreting whole-genome telomere length in idiopathic pulmonary fibrosis
Southern, B. D., & Wolters, P. J. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamag348
Mapping the dialogue: Decoding alveolar stem–niche interactions
Nabhan, A. N., Biton, A., Everrett, C., Foo, C., Wu, D., Webster, J. D., Alam, A. A., Penna, E., Rost, S., Rohatgi, N., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2606113123
“Dysfunction of this stem–niche system underlies lung adenocarcinoma (5, 7) and pulmonary fibrosis (8–10), and can impact viral diseases such as COVID - 19 (11, 12).”
Interstitial Lung Disease In Older Adults
Chiang, G. C., Shao, S., & Antin-Ozerkis, D. E. (2026) · Respiratory medicine · doi:10.1007/978-3-032-29861-4_15
Okereke, J., Craig, A., Rojas, M., Degioanni, B., Lieberman, A. E., Sembrat, J., Evankovich, J., Bain, W., Bahudhanapati, H., Kass, D. J., et al. (2026) · Mucosal Immunology · doi:10.1016/j.mucimm.2026.100387 · Cited by 1
Self-citationMocci, S., Littera, R., Deidda, S., Cannas, F., Cocco, C., Lorrai, M., Mereu, C., Murgia, M., Nutile, G., Lai, F., et al. (2026) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2025-003625
“For instance, apoptotic cells produce IL-10 and TGF-β , necrotic cells release IL-1 α , necroptotic cells secrete IL-8, IL-1, CXCL2 and cyclophilin A, while pyroptotic cells release IL-1 β , IL-18, TNF-α and IL-6.”
Advances and challenges in cell-based therapy for lung diseases
Wallman, D. J., Alhawach, V., Hawkins, F. J., & Lynch, T. J. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102971 · Cited by 1
Brasseur, C., Ba, I., Revy, P., Kannengiesser, C., Guyard, A., Baccary, T., Jaillet, M., Mailleux, A., Crestani, B., Borie, R., et al. (2026) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2026.07.010
Inter‐Organ Communication in Pulmonary Fibrosis: Systemic Modifiers of a Lung‐Centered Disease
Wan, R., Qin, Z., Wang, Z., & Xu, K. (2026) · The FASEB Journal · doi:10.1096/fj.202603126
Yang, L., Huang, Y., Liu, A., Yan, Y., Liu, B., & Yuan, X. (2026) · Biomedicines · doi:10.3390/biomedicines14102265
Mahieu, M., Defour, J., Mathieu, B., Richiardone, E., Heremans, I. P., Fabiole, E., Levy, G., Berre, G. L., Scheers, I., Brichard, B., et al. (2026) · eLife · doi:10.7554/elife.111391.2.sa0
Metadata
- Authors
- Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., Phillips, J. A., Lansdorp, P. M., Loyd, J. E., & Armanios, M. Y.
- Affiliations
- Johns Hopkins University (US)
- Arizona State University (US)
- Vanderbilt University (US)
- BC Cancer Agency (CA)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13051-13056
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529100
- OpenAlex
- W2147238277
- Cited by
- 805
- References
- 35
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 38 · 2023: 48 · 2022: 45 · 2021: 61 · 2020: 53 · 2019: 60 · 2018: 54 · 2017: 40 · 2016: 36 · 2015: 56 · 2014: 45 · 2013: 45 · 2012: 40
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation
- Johns Hopkins University
- National Institutes of Health
- U.S. Public Health Service (T32 60441, K08 118416)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, idiopathic interstitial pneumonia, telomere length, short telomeres, telomerase mutations, hTERT, hTR, leukocytes, alveolar epithelial cells, cryptogenic cirrhosis, disease risk
- MeSH terms
- Epithelium, Family, Fibrosis, Heterozygote, Humans, Leukocytes, Mononuclear, Pulmonary Alveoli, Pulmonary Fibrosis, Risk Factors, RNA, Tomography, X-Ray Computed, Biomarkers, Case-Control Studies, Telomere, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.